期刊文献+

慢性阻塞性肺疾病急性加重的预防对策 被引量:14

Prevention of acute exacerbation of chronic obstructive pulmonary disease
下载PDF
导出
摘要 急性加重是慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)疾病进程中的重要事件,给患者的生活和疾病病程造成严重后果,同时带来巨大的社会和经济负担,急性加重的预防有着重要的临床意义。研究证实长效支气管舒张药、吸入性糖皮质激素、磷酸二酯酶4抑制药、茶碱、抗氧化药、免疫调节药、大环内酯类抗生素、疫苗等药物治疗可有效预防COPD急性加重的发生。非药物干预如肺康复、氧疗及无创机械通气等在预防COPD急性加重中也发挥一定的作用。 Acute exacerbation is an important event in the development of chronic obstructive pulmonary disease(COPD). It is now known that acute exacerbations can negatively affect patients' quality of life and natural course of COPD, leading to heavy burden of society and economy. Preventive measures are very important for acute exacerbations of COPD. Long-acting bronchodilators, inhaled corticosteroids, phosphodiesterase 4 inhibitor, theophylline, antioxidants, immunomodulators, macrolides, and vaccine have been demonstrated to be efficient in prevention of COPD development. Non-pharmacological interventions, such as rehabilitation, long-term oxygen therapy, and non-invasive ventilation, are also useful strategies to prevent the acute exacerbations in patients with COPD.
作者 陈珊珊 陈平
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2014年第8期861-867,共7页 Journal of Central South University :Medical Science
基金 国家临床重点专科建设项目和国家自然科学基金(81370143 81170036)~~
关键词 慢性阻塞性肺疾病 急性加重 预防 chronic obstructive pulmonary disease exacerbations prevention
  • 相关文献

参考文献6

二级参考文献90

  • 1陈建,王广发.慢性阻塞性肺疾病全球倡议2011修订版解读[J].中国医学前沿杂志(电子版),2012,4(1):42-44. 被引量:65
  • 2徐锋,徐作军,梁希军.小剂量罗红霉素增加稳定期慢性阻塞性肺疾病常规治疗疗效的研究[J].国外医学(呼吸系统分册),2005,25(11):804-807. 被引量:18
  • 3欧相林,黄江,曾祥毅.长期小剂量克拉霉素对稳定期慢性阻塞性肺疾病的疗效观察[J].实用医学杂志,2006,22(13):1558-1559. 被引量:8
  • 4Fabbri LM, Calverley PM, Izquierdo-Alnnso JL, et al, M2-127 and M2-128 study groups. Roflumilast in moderate-to-severe chronic ob- structive pulmonary disease treated with long-acting bronchodilators two randomized clinical trials [ J ]. Lancet,2009,374:695- 703. 被引量:1
  • 5Zheng JP, Kang J, Huang SG, et al. Effect of carboeisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study) : a randomised placebo-controlled study [ J ]. Lancet, 2008, 371:2013 - 2018. 被引量:1
  • 6Rennard SI,Fogarty C, Kelsen S, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary dis- ease[ J]. Am J Respir Crit Care Med ,2007,175:926- 934. 被引量:1
  • 7Stolz D, Rasch H, Linka A, et al. A randomized, controlled tri al of bosentan in severe COPD [ J]. Eur Respir J,2008,32 619-628. 被引量:1
  • 8Celli BR ,Thomas NE, Anderson. JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease:result from the TORCH study [ J ]. Am J Respir Crit Care Med,2008,178:332- 338. 被引量:1
  • 9Donohue JF, Hanania NA, Fogarty C, et al. Long - term safety of nebulized formoterol:resuhs of a twelve - month open - label clini- cal trial[ J]. Ther Adv Respir Dis,2008,2 : 199- 2208. 被引量:1
  • 10Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsive- ness in patients with COPD[J]. Eur Respir J,2008,31:742-2750. 被引量:1

共引文献792

同被引文献148

引证文献14

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部